Siatis Perry C

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Siatis Perry C's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
131.75
Quantity 60,817 -22.6%
Value US$3,166,181
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
126.24
Quantity 68,595 +11.9%
Value US$1,167,248
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
411.84
Quantity 10,125 -9.4%
Value US$2,597,440
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
234.39
Quantity 18,668
Value US$4,375,585
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
230.00
Quantity 22,381 -37.0%
Value US$5,147,630
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
230.00
Quantity 22,381
Value US$5,147,630
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
210.00
Quantity 18,008 -79.6%
Value US$3,781,680
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
210.00
Quantity 18,008
Value US$3,781,680
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
207.19
Quantity 363 -7.3%
Value US$75,210
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
206.62
Quantity 6,811 -57.8%
Value US$1,407,289
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
205.38
Quantity 2,718 -18.7%
Value US$558,223
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
206.31
Quantity 9,892
Value US$2,040,790
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
198.12
Quantity 3,994 -15.1%
Value US$791,291
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
197.40
Quantity 1,784 -6.3%
Value US$352,162
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
197.90
Quantity 5,778
Value US$1,143,492
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
178.04
Quantity 3,387 -24.6%
Value US$603,021
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
177.05
Quantity 6,504 -32.1%
Value US$1,151,533
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
177.27
Quantity 9,911
Value US$1,756,912
US Abbvie Inc (ABBV)
Transaction date
Planned sale
Price
177.51
Quantity 13,753 -32.8%
Value US$2,441,295
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
177.51
Quantity 13,753
Value US$2,441,327
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
170.00
Quantity 2,919
Value US$496,230
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
160.00
Quantity 3,520 -25.3%
Value US$563,200
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.38
Quantity 805 -7.2%
Value US$123,471
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
153.06
Quantity 11,330 -50.3%
Value US$1,734,170
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
151.29
Quantity 3,933 -10.9%
Value US$595,024
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
150.73
Quantity 3,431 -8.7%
Value US$517,155
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-03 2026-03-02
US Abbvie Inc (ABBV)
S Sale
60,817 -22.6%
131.75
US$3,166,181 		60,817 -22.6% 131.75 US$3,166,181
2026-03-03 2026-03-02
US Abbvie Inc (ABBV)
S Sale
68,595 +11.9%
126.24
US$1,167,248 		68,595 +11.9% 126.24 US$1,167,248
2026-03-03 2026-03-02
US Abbvie Inc (ABBV)
S Sale
10,125 -9.4%
411.84
US$2,597,440 		10,125 -9.4% 411.84 US$2,597,440
2026-03-02 2026-03-02
US Abbvie Inc (ABBV)
PrS Proposed sale
18,668
234.39
US$4,375,585 		18,668 234.39 US$4,375,585
2026-02-27 2026-02-25
US Abbvie Inc (ABBV)
S Sale
22,381 -37.0%
230.00
US$5,147,630 		22,381 -37.0% 230.00 US$5,147,630
2026-02-25 2026-02-25
US Abbvie Inc (ABBV)
PrS Proposed sale
22,381
230.00
US$5,147,630 		22,381 230.00 US$5,147,630
2025-03-04 2025-03-03
US Abbvie Inc (ABBV)
S Sale
18,008 -79.6%
210.00
US$3,781,680 		18,008 -79.6% 210.00 US$3,781,680
2025-03-03 2025-03-03
US Abbvie Inc (ABBV)
PrS Proposed sale
18,008
210.00
US$3,781,680 		18,008 210.00 US$3,781,680
2025-03-04 2025-02-28
US Abbvie Inc (ABBV)
S Sale
363 -7.3%
207.19
US$75,210 		363 -7.3% 207.19 US$75,210
2025-03-04 2025-02-28
US Abbvie Inc (ABBV)
S Sale
6,811 -57.8%
206.62
US$1,407,289 		6,811 -57.8% 206.62 US$1,407,289
2025-03-04 2025-02-28
US Abbvie Inc (ABBV)
S Sale
2,718 -18.7%
205.38
US$558,223 		2,718 -18.7% 205.38 US$558,223
2025-02-28 2025-02-28
US Abbvie Inc (ABBV)
PrS Proposed sale
9,892
206.31
US$2,040,790 		9,892 206.31 US$2,040,790
2025-02-24 2025-02-20
US Abbvie Inc (ABBV)
PlS Planned sale
3,994 -15.1%
198.12
US$791,291 		3,994 -15.1% 198.12 US$791,291
2025-02-24 2025-02-20
US Abbvie Inc (ABBV)
PlS Planned sale
1,784 -6.3%
197.40
US$352,162 		1,784 -6.3% 197.40 US$352,162
2025-02-20 2025-02-20
US Abbvie Inc (ABBV)
PrS Proposed sale
5,778
197.90
US$1,143,492 		5,778 197.90 US$1,143,492
2024-03-01 2024-02-29
US Abbvie Inc (ABBV)
PlS Planned sale
3,387 -24.6%
178.04
US$603,021 		3,387 -24.6% 178.04 US$603,021
2024-03-01 2024-02-29
US Abbvie Inc (ABBV)
PlS Planned sale
6,504 -32.1%
177.05
US$1,151,533 		6,504 -32.1% 177.05 US$1,151,533
2024-02-29 2024-02-29
US Abbvie Inc (ABBV)
PrS Proposed sale
9,911
177.27
US$1,756,912 		9,911 177.27 US$1,756,912
2024-02-27 2024-02-23
US Abbvie Inc (ABBV)
PlS Planned sale
13,753 -32.8%
177.51
US$2,441,295 		13,753 -32.8% 177.51 US$2,441,295
2024-02-23 2024-02-23
US Abbvie Inc (ABBV)
PrS Proposed sale
13,753
177.51
US$2,441,327 		13,753 177.51 US$2,441,327
2024-02-02 2024-02-02
US Abbvie Inc (ABBV)
PrS Proposed sale
2,919
170.00
US$496,230 		2,919 170.00 US$496,230
2023-04-05 2023-04-03
US Abbvie Inc (ABBV)
S Sale
3,520 -25.3%
160.00
US$563,200 		3,520 -25.3% 160.00 US$563,200
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
805 -7.2%
153.38
US$123,471 		805 -7.2% 153.38 US$123,471
2023-03-02 2023-03-01
US Abbvie Inc (ABBV)
S Sale
11,330 -50.3%
153.06
US$1,734,170 		11,330 -50.3% 153.06 US$1,734,170
2023-02-22 2023-02-21
US Abbvie Inc (ABBV)
S Sale
3,933 -10.9%
151.29
US$595,024 		3,933 -10.9% 151.29 US$595,024
2023-02-22 2023-02-21
US Abbvie Inc (ABBV)
S Sale
3,431 -8.7%
150.73
US$517,155 		3,431 -8.7% 150.73 US$517,155